Nicholas Keen

Insider Reports History

Entity
Individual
Location
C/O Bicycle Theapeutics Limited, B900 Babraham Research Campus, Cambridge, United Kingdom
Signature
/s/ Laura Berezin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Keen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BICYCLE THERAPEUTICS PLC CHIEF SCIENTIFIC OFFICER Ordinary Shares 62K $1.22M $19.64 Jul 3, 2024 Direct
BICYCLE THERAPEUTICS PLC CHIEF SCIENTIFIC OFFICER Ordinary Shares 7K $137K $19.64 Jul 3, 2024 By GRAT
BICYCLE THERAPEUTICS plc CHIEF SCIENTIFIC OFFICER Employee Stock Option (right to buy) 56K Jan 2, 2024 Direct

Insider Reports Filed by Nicholas Keen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCYC BICYCLE THERAPEUTICS PLC Jul 3, 2024 1 -$15.3K 4 Jul 8, 2024 CHIEF SCIENTIFIC OFFICER
BCYC BICYCLE THERAPEUTICS plc Apr 3, 2024 1 -$18.8K 4 Apr 5, 2024 CHIEF SCIENTIFIC OFFICER
BCYC BICYCLE THERAPEUTICS plc Jan 2, 2024 3 -$46.2K 4 Jan 4, 2024 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Oct 3, 2023 1 -$5.44K 4 Oct 5, 2023 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Jul 3, 2023 1 -$8.43K 4 Jul 6, 2023 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Apr 3, 2023 1 -$6.73K 4 Apr 5, 2023 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2023 3 -$52.8K 4 Jan 5, 2023 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Dec 21, 2021 2 $217K 4 Dec 22, 2021 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Oct 1, 2021 2 -$152K 4 Oct 5, 2021 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Sep 15, 2021 2 -$223K 4 Sep 17, 2021 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Sep 2, 2021 1 -$400K 4 Sep 3, 2021 Chief Scientific Officer
BCYC BICYCLE THERAPEUTICS plc Jul 14, 2021 1 -$350K 4 Jul 16, 2021 Chief Scientific Officer